Argenx Agrees to Acquire Unnatural Products for Up to $1.15 Billion
Argenx will pay $550 million in cash upfront, with the total price reaching up to $1.15 billion. The acquisition brings Unnatural Products’ peptide-discovery technology in-house.
By Adria CalatayudArgenx said it agreed to acquire California-based biotech company Unnatural Products for up to $1.15 billion, bringing peptide-discovery technology in-house.The Amsterdam-based biotech company said Monday that it will pay $550 million in cash upfront for Unnatural Products, and up…